New approaches for the treatment of Alzheimers disease
The bottom line Basal insulin and GLP-1 combinations like Xultophy and Soliqua can be a great option for managing type 2 diabetes
Before starting Ozempic, patients undergo a comprehensive evaluation to determine if they are suitable candidates
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last Weight Watchers launches a fully integrated platform for the GLP-1 era NEW YORK, Dec
PlexusDx serves all 50 states, requires no insurance, charges no membership fees, and accepts HSA and FSA payments for additional savings
Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, has emerged as the commercial powerhouse, with the oral version launching in January 2026 following December 2025 FDA approval [3]